Quick Answer
Vir Biotechnology, Inc. reported Total Assets of $1.00 billion for fiscal year 2025.
Vir Biotechnology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.00B | -28.3% |
| 2024 | $1.40B | -27.1% |
| 2023 | $1.92B | -31.5% |
| 2022 | $2.80B | +43.4% |
| 2021 | $1.95B | +112.7% |
| 2020 | $918.76M | +79.4% |
| 2019 | $512.07M | +167.3% |
| 2018 | $191.60M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.02B | -32.0% | -14.5% |
| June 30, 2025 | $1.19B | -28.6% | -8.8% |
| March 31, 2025 | $1.31B | -27.1% | -6.5% |
| December 31, 2024 | $1.40B | -27.1% | -6.6% |
| September 30, 2024 | $1.50B | -26.7% | -10.3% |
| June 30, 2024 | $1.67B | -25.6% | -6.9% |
| March 31, 2024 | $1.79B | -32.7% | -6.5% |
| December 31, 2023 | $1.92B | -31.5% | -6.2% |
- Vir Biotechnology, Inc. showed a decrease of -28.3% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Vir Biotechnology, Inc.’s total assets has grown by 423.4% (from $191.60 million to $1.00 billion).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: